Applications are now open for the 2026 UK Switzerland Collaborative Research and Development Round 3 Fully Funded Emerging Technology Support. Expanding a deep technology enterprise into international markets represents a monumental milestone, but managing the immense financial risks and coordinating secure cross border research can feel like an insurmountable barrier. Finding a bilateral program that covers your project development costs while partnering you with world class researchers is incredibly rare. The 2026 UK Switzerland Collaborative Research and Development Round 3 program, powered by Innovate UK and Innosuisse, is a premier initiative designed to solve this issue.
Join our Telegram Channel for Instant Scholarship Updates
By offering joint international innovation grants, this program ensures that exceptional technology developers can focus entirely on pioneering breakthroughs, building strong bilateral connections, and achieving commercial excellence at registered organizations in both the United Kingdom and Switzerland.
UK Switzerland CR and D Round 3 Summary Table
| Detail Category | Value Information |
|---|---|
| Host Organisations | Innovate UK and Swiss Innosuisse |
| Target Audience | UK Registered Businesses and Swiss Implementation Partners |
| Primary Benefit | Grants up to 450,000 Pounds per UK Project |
| Program Type | Fully Funded Bilateral Collaborative R and D |
| Project Duration | 18 to 36 months |
| Study Location | United Kingdom and Switzerland |
| Application Deadline | September 3 2026 at 11:00 am UK Time |
About the 2026 UK-Switzerland Collaborative Research and Development Round 3 (Fully Funded Emerging Technology Support)
The UK Switzerland Collaborative Research and Development program is much more than a standard corporate subsidy. It is a complete bilateral business development platform designed to empower the next generation of global technology leaders, clinical innovators, and cellular biologists. Operating through the official online application portals of both nations, this highly competitive initiative invites investigators to contribute to vital scientific discoveries and industrial solutions.
The program is awarded entirely on a merit basis, with up to 3 million Pounds from Innovate UK and at least 3 million Swiss Francs from Innosuisse allocated to fund high quality projects. Recognizing that advanced scientific analysis is most successful when scholars can work without financial stress, the program supports selected consortia for a period of up to three years. Thanks to this international alliance, special consideration is given to projects that demonstrate a balanced technological contribution and clear economic benefits for both participating nations.
Benefits of the UK-Switzerland CR&D Round 3 Fellowship
- Generous Financial Support: Receive up to 450000 Pounds in direct grant funding per UK project partner.
- Balanced Bilateral Funding: Each country funds its eligible participants directly, reducing international administrative delays.
- Flexible Project Parameters: Projects can last between 18 to 36 months to accommodate complex industrial testing.
- Direct Industry Mentorship: Partner with esteemed Swiss technology giants and advanced research institutes.
- Advanced Computing Access: Gain full access to modern campus laboratories, computing facilities, and library databases.
- Elite Enterprise Networking: Join an active community of past innovators who are leading figures in European technology and medicine.
Strategic Focus Areas of the Joint Initiative
The principal mission of this program is to support industrial research and experimental development that will benefit industries in both countries. Consortia may submit proposals examining any aspect of emerging technology, particularly within the following strategic areas:
- Semiconductors: Designing, manufacturing, and developing advanced packaging solutions or microelectronics applications.
- Life Sciences: Accelerating the development of predictive therapeutics, advanced diagnostics, medical devices, and digital health systems.
- Engineering Biology: Advancing synthetic biology, genomic editing, biomaterials, and innovative biomanufacturing processes.
Why This Program Boosts Your Future Career and Business
Securing one of these highly competitive research awards serves as an exceptional catalyst for your academic and professional path. Winning a place in this cohort gives you immediate access to advanced bilateral technology funding, connecting you with top tier industry experts, international mentors, and professional development networks. This elite recognition helps you establish robust credentials and stand out when applying for future venture capital funding, massive national research awards, or senior corporate leadership positions.
Furthermore, participating in these semiconductors research sponsorships allows you to focus on publishing high quality papers, designing innovative methodologies, or generating critical preliminary data. The financial security provided by this award enables you to collaborate on life sciences and engineering biology career development funding paths, present your findings at major global venues, and share your scientific insights. Having your research journey backed by prestigious institutes like Innovate UK and Innosuisse prepares you to lead massive industrial trials and transition into senior leadership roles within global health advocacy, academic medicine, or biotechnology.
Co-Funding Rules and Host Organisation Contribution Rates
This fellowship provides significant financial support, but economic host organizations in the United Kingdom must co fund their projects based on their enterprise size and the category of research proposed:
- Category 2 Industrial Research Projects: Small and micro organisations can claim up to 70 percent of eligible project costs. Medium sized businesses can receive up to 60 percent, while large enterprises can claim up to 50 percent of their costs.
- Category 2 Experimental Development Projects: These closer to market projects are funded up to 45 percent for small and micro businesses, up to 35 percent for medium sized businesses, and up to 25 percent for large organisations.
- Research Participation Limitations: UK research organizations undertaking non economic activity can share up to 30 percent of the total eligible UK project costs. Academic institutions can receive up to 80 percent of full economic costs utilizing the Transparent Approach to Costing methodology.
- Overheads and Subcontractors: Subcontractor costs are allowed but are strictly limited to no more than 20 percent of the total eligible UK project costs.
Consortia Rules and Participant Time Divisions
To ensure a balanced bilateral relationship, the program enforces strict rules on resource allocation and time commitment:
- Non Linked Partnership: The consortium must include at least one UK registered business and one Swiss business that are completely separate legal entities and not linked under a parent company.
- Research Institute Requirement: Consortia must include at least one research institute from either country. This requirement is waived if the Swiss applicant is a start up, pre market entity with less than 50 FTE staff.
- Person Month Calculations: One person month is defined as 154 hours of full time work. No single partner or country can contribute more than 70 percent or less than 30 percent of the total person months dedicated to the project.
- Domestically Exploited Results: UK partners must carry out the majority of their project work within the United Kingdom and demonstrate a clear intention to commercially exploit the results from or in the UK.
Eligibility and Requirements of the UK-Switzerland CR&D Round 3 Funding
- UK Lead Status: Must be a UK registered business of any size that starts the application on the Innovation Funding Service portal.
- Target Audience: Must involve at least one grant claiming micro, small, or medium sized enterprise based in the United Kingdom.
- Swiss Partner Alignment: Must collaborate with at least one non linked Swiss business applying under the parallel Innosuisse program.
- Strategic Alignment: Proposal must address innovation in Semiconductors, Life Sciences, or Engineering Biology.
- Safety Screenings and Animal Welfare: Ensure all proposed work complies with the UKRI guidelines on animal welfare and human participation.
- Regulatory Compliance: Disclose all current and potential alternative funding sources and ensure no sanctions violations exist.
Required Documents for the Application
- Detailed Research and Innovation Proposal: A comprehensive project plan detailing your scientific aims, background, methodology, and projected benefits.
- Technical Appendix: A maximum two page PDF document containing high resolution diagrams, charts, and technical illustrations.
- Project Plan and Gantt Chart: A detailed two page PDF appendix outlining work packages, milestones, and team dependencies.
- Complete Risk Register: A comprehensive two page PDF document outlining technical, commercial, and environmental risks along with mitigation plans.
- Transparent Approach to Costing Sheet: Completed financial costing forms for participating academic institutions.
Step by Step Application Guide
Phase 1: Strategic Matchmaking and Non Linked Partnerships
- Identify a complementary Swiss business partner who is applying to Innosuisse for the Swiss component.
- Verify that your partner is a separate legal entity and not linked to your UK organization.
- Select an eligible research institute from either the UK or Switzerland to join your consortium.
- Confirm if the Swiss partner is a start up with less than 50 FTE to see if the research institute requirement is waived.
Phase 2: Person Months Allocation and Technical Scope
- Design your research plan to focus on semiconductors, life sciences, or engineering biology.
- Calculate the time commitment of all staff, ensuring no single country contributes more than 70 percent or less than 30 percent of the total person months.
- Verify that one person month is set exactly to 154 hours of full time work.
- Establish your project duration to fit within the limits of 18 to 36 months and set the start date to February 1 2027.
Phase 3: Financial Portal Setup and Subcontractor Auditing
- Navigate to the official Innovation Funding Service portal on your primary device.
- Create a secure lead applicant account using your professional UK corporate email address.
- Enter your project costs, ensuring that any subcontractor costs do not exceed 20 percent of the total eligible UK participation budget.
- Invite your UK project partners to log in and enter their respective eligible costs.
Phase 4: Mandatory Document Writing and Page Formatting
- Write a detailed public description and project summary, keeping each under the strict limit of four hundred words.
- Draft your answers for questions 8 through 17, ensuring no answer exceeds the maximum length of four hundred words.
- Compile your Gantt chart, risk register, and technical illustrations into individual PDF files.
- Ensure each PDF appendix is no larger than 10 MB and does not exceed exactly two A4 pages.
Phase 5: Synchronized Dual Application Submission
- Coordinate with your Swiss partner to ensure that the project title submitted to the Innovation Funding Service is identical to the one submitted to Innosuisse.
- Convert all your financial sheets and academic costing summaries into clear PDF documents.
- Upload all completed appendices and submit your finalized application package before the strict deadline on Thursday September 3 2026 at 11:00 am UK time.
- Monitor your registered portal and inbox regularly for the official applicant notifications on November 30 2026.
Selection Process and Timeline
- June 23 2026: Official online briefing event and slide deck distribution.
- July 1 2026: Competition officially opens for submissions on the Innovation Funding Service.
- September 3 2026 (11:00 AM UK Time): Hard closing deadline for all UK applications and financial sheets.
- November 30 2026: Official notification of application outcomes sent to all candidates.
- February 1 2027: Earliest official start date for successful collaborative research projects.
Common Mistakes to Avoid
- Non Identical Project Titles: Submitting the application with different project titles on the Innovation Funding Service and Innosuisse portals, which leads to immediate exclusion.
- Exceeding Subcontractor Caps: Budgeting subcontractor costs above the strict limit of 20 percent of the total eligible UK project costs.
- Linked Company Conflict: Applying with a Swiss partner that is legally linked to the UK lead organisation, which invalidates the consortium requirements.
- Imbalanced Time Allocations: Allocating more than 70 percent or less than 30 percent of total person months to a single country.
- Late Submissions: Missing the strict closing deadline on Thursday September 3 2026 at 11:00 am UK time.
Deadline: September 3 2026 (11:00 AM UK Time)
Frequently Asked Questions (FAQ) About the UK-Switzerland CR&D Round 3
Q1: Who is eligible to lead the application on the IFS portal? A1: The lead applicant must be a UK registered business of any size that collaborates with an eligible Swiss partner.
Q2: What are the specific strategic technology areas funded under Round 3? A2: This competition specifically funds innovative projects in Semiconductors, Life Sciences, and Engineering Biology.
Q3: What is the maximum grant funding request for the UK portion of the project? A3: The total grant funding request for the UK project partners must be no greater than 450000 Pounds.
Q4: Do Swiss partners receive funding from Innovate UK? A4: No, Swiss partners will not receive any UK funding, they must apply to and be funded by Innosuisse.
Q5: What is the project duration limit? A5: Funded projects must have a duration of between 18 to 36 months and start on February 1 2027.
Q6: What is a person month under Innosuisse and Innovate UK rules? A6: One person month is defined as cumulative work of 154 hours of full time work allocated to the project.
Q7: What are the limits on subcontractor costs for the UK team? A7: Subcontractor costs must not exceed 20 percent of the total eligible UK project costs.
Q8: Why is a research institute required in the consortium? A8: Consortia must include a research institute to encourage bilateral academic cooperation, unless the Swiss partner is a start up with less than 50 FTE.
Q9: What is the historical success rate for this competition? A9: Historical success rates from similar highly competitive rounds suggest that candidates have an 11 percent chance of success.
Q10: Where do I submit my completed application? A10: UK partners must submit their completed portfolios digitally through the official Innovation Funding Service portal of Innovate UK.
